A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients
- Status
- RECRUITING
- Phase
- NA
Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer
- Status
- COMPLETED
- Phase
- NA
Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Milademetan in Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE3
Axitinib + Ipilimumab in Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of SEA-CD40 Given With Other Drugs in Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma
- Status
- COMPLETED
- Phase
- PHASE2
Using QPOP to Predict Treatment for Sarcomas and Melanomas
- Status
- RECRUITING
- Phase
- N/A
Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1